Metrasens Global MRI Safety Business Obtains another Patent

A leading provider of advanced magnetic detection technologies, Metrasens has proudly announced about the recent grant for a new patent by the US Patent and Trademark Office (USPTO) for further strengthening of its patent portfolio. The newly granted patent revolves around the protection of the technology proficient in decreasing alarm weakness in the Ferromagnetic Detection Systems (FMDS) of Metrasens. Being used to increase the safety of staff and patients in the MRI departments of hospitals, Metrasens’ FMDS systems for MRI safety were invented by the company’s founders and have been purchased by MRI departments in 36 countries since 2003, when they were first introduced globally.

By obtaining its first patent before 2000 along with a total of 21 international patents till now, Metrasens at present has a considerable Intellectual Property (IP) in the field of magnetic detection. Nevertheless, this family’s patent protection granted in China is currently subject to a challenge by Nanjing Cloud Magnet Electronic Technology Company Limited in the China State Intellectual Property Office (SIPO). Metrasens is defending itself against the plaintiff and its affiliate – Nanjing Haole Technology Company Limited (NH) in the Nanjing Intermediate Court for Copyright Infringement and in the Shanghai Intellectual Property Court for Patent Infringement. A decision announced by SIPO in regards to this case has proclaimed that the office concludes the patent to be invalid because it lacks an inventive step. It appears that Metrasens will robustly appeal to the SIPO decision.

Metrasens with an intention to defend itself claimed that previously, Nanjing Haole Technology Company Limited was a distributor appointed to disseminate its Ferroguard FMDS products in Southern China. Metrasens had terminated the relationship as it found this group emerging and selling products that possessed very similar technical features and functions to those for which Metrasens had obtained patents. With the aid of Beijing Yihai (one of its distributors), Metrasens has evolved as a leader in providing MRI safety services and resolutions to hospitals throughout China. Metrasens also has a Patent Application having further eight patents that reflect its investment to develop technology that helps in keeping the Chinese citizens safe.

Metrasens’ CEO and co-founder, Dr. Simon Goodyear, said that their close connections with MRI system vendors and the Chinese radiology community facilitated the fast and accelerating adoption of their Ferroguard systems in China.They are proud that both the IP executives and the MRI community value the benefits of their products, which are the result of years of their experience in this field. The new patent will help them in continuing to pursue their goals of safeguarding Metrasens’ intellectual property and businesses and of improving patient safety in China. For more visit: https://www.trademarkmaldives.com